Medical Grand Rounds - Kawasaki Disease 2020 Update
Presenter: David Bleich, MD, Chief, Division of Endocrinology, Diabetes & Metabolism, Associate Professor of Medicine, Rutgers New Jersey Medical School, Newark, NJ
At the conclusion of this activity, participants should be able to:
- Describe complications from Kawasaki Disease.
- Describe the very distinctive epidemiology and its etiologic implications.
- Describe treatment of high-risk patients
- Identify Multisystem Inflammatory Syndrome due to SARS-CoV-2.
- Review plasmablast (antibody) response to Kawasaki Disease.
Date: Friday, December 18, 2020
Time: 12 p.m.
Location: Microsoft Teams - E-mail Trish.Stern@Guthrie.org to be included
This program is intended for: Physicians, Advanced Practice Providers, Fellows, Residents, Medical and Nursing Students, and other Ancillary Healthcare Professionals.
“The Guthrie Clinic is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.”
“The Guthrie Clinic designates this live activity for a maximum of (1.0) AMA PRA Category I Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.”
Disclosure/Conflict of Interest Statement
“Faculty and all others who have the ability to control the content of continuing medical education activities sponsored by The Guthrie Clinic are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).” The presenter and all other persons planning the content of this program have indicated they DO NOT have any significant commercial interests that may bias the presentation.